GRFS Grifols, S.A.

NASDAQ
$7.30

Grifols, S.A. (GRFS) is expected to report earnings on October 12, 2026, after the market close. The consensus earnings estimate is $0.30 per share.

Earnings Date
3rd Quarter, Sep 2026
Oct 12
Monday · After Close
Earnings Whisper
-
vs $0.30
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Grifols, S.A.

Grifols SA is a specialty biopharmaceutical company that develops, manufactures and distributes a broad range of plasma derivative products. It operates in four business divisions: Bioscience, Diagnostic, Hospital and Raw Materials and Others.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.